- Home
- RCON vs STRO Comparison
RCON vs STRO Comparison
Compare RCON & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- STRO
- Stock Information
- Founded
- RCON 2007
- STRO 2003
- Country
- RCON China
- STRO United States
- Employees
- RCON N/A
- STRO N/A
- Industry
- RCON Oilfield Services/Equipment
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCON Energy
- STRO Health Care
- Exchange
- RCON Nasdaq
- STRO Nasdaq
- Market Cap
- RCON 45.3M
- STRO 50.0M
- IPO Year
- RCON 2009
- STRO 2018
- Fundamental
- Price
- RCON $1.66
- STRO $1.18
- Analyst Decision
- RCON
- STRO Buy
- Analyst Count
- RCON 0
- STRO 7
- Target Price
- RCON N/A
- STRO $6.83
- AVG Volume (30 Days)
- RCON 13.3K
- STRO 1.8M
- Earning Date
- RCON 06-28-2024
- STRO 05-12-2025
- Dividend Yield
- RCON N/A
- STRO N/A
- EPS Growth
- RCON N/A
- STRO N/A
- EPS
- RCON N/A
- STRO N/A
- Revenue
- RCON $8,996,572.00
- STRO $62,043,000.00
- Revenue This Year
- RCON N/A
- STRO N/A
- Revenue Next Year
- RCON $12.17
- STRO $1.29
- P/E Ratio
- RCON N/A
- STRO N/A
- Revenue Growth
- RCON N/A
- STRO N/A
- 52 Week Low
- RCON $1.32
- STRO $0.52
- 52 Week High
- RCON $3.70
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- RCON 49.18
- STRO 57.04
- Support Level
- RCON $1.45
- STRO $0.52
- Resistance Level
- RCON $1.97
- STRO $0.78
- Average True Range (ATR)
- RCON 0.14
- STRO 0.10
- MACD
- RCON -0.01
- STRO 0.06
- Stochastic Oscillator
- RCON 44.23
- STRO 99.87
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.